KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Profit After Tax: 2009-2025

Historic Profit After Tax for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $434.0 million.

  • Teva Pharmaceutical Industries' Profit After Tax rose 199.31% to $434.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $662.0 million, marking a year-over-year increase of 152.41%. This contributed to the annual value of -$2.0 billion for FY2024, which is 218.54% down from last year.
  • Teva Pharmaceutical Industries' Profit After Tax amounted to $434.0 million in Q3 2025, which was up 53.36% from $283.0 million recorded in Q2 2025.
  • Teva Pharmaceutical Industries' 5-year Profit After Tax high stood at $467.0 million for Q4 2023, and its period low was -$1.3 billion during Q4 2022.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Profit After Tax value was -$253.0 million (recorded in 2023), while the average stood at -$153.0 million.
  • In the last 5 years, Teva Pharmaceutical Industries' Profit After Tax plummeted by 1,236.90% in 2022 and then surged by 199.31% in 2025.
  • Teva Pharmaceutical Industries' Profit After Tax (MRQ) stood at -$152.0 million in 2021, then tumbled by 776.97% to -$1.3 billion in 2022, then skyrocketed by 135.03% to $467.0 million in 2023, then tumbled by 158.89% to -$275.0 million in 2024, then skyrocketed by 257.82% to $434.0 million in 2025.
  • Its last three reported values are $434.0 million in Q3 2025, $283.0 million for Q2 2025, and $220.0 million during Q1 2025.